|
KPNA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59834999999831E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21480000012409E-07 |
| Normal-vs-Stage2 |
7.774500E-02 |
| Normal-vs-Stage3 |
1.054560E-01 |
| Normal-vs-Stage4 |
3.342600E-01 |
| Stage1-vs-Stage2 |
3.101400E-01 |
| Stage1-vs-Stage3 |
8.088300E-02 |
| Stage1-vs-Stage4 |
2.727200E-01 |
| Stage2-vs-Stage3 |
7.051200E-01 |
| Stage2-vs-Stage4 |
8.060800E-01 |
| Stage3-vs-Stage4 |
9.746000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96669999996679E-06 |
| Normal-vs-AfricanAmerican |
3.320100E-03 |
| Normal-vs-Asian |
9.881700E-03 |
| Caucasian-vs-AfricanAmerican |
4.868200E-01 |
| Caucasian-vs-Asian |
7.346800E-01 |
| AfricanAmerican-vs-Asian |
6.142400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.69970000027686E-07 |
| Normal-vs-Female |
6.734100E-02 |
| Male-vs-Female |
2.250500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.402600E-04 |
| Normal-vs-Extreme_Weight |
4.96969999597141E-08 |
| Normal-vs-Obese |
2.342500E-02 |
| Normal-vs-Extreme_Obese |
5.950200E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.297400E-01 |
| Normal_Weight-vs-Obese |
1.374240E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.051400E-01 |
| Extreme_Weight-vs-Obese |
9.062600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.992400E-01 |
| Obese-vs-Extreme_Obese |
1.554190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.903900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.297000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.24630000050996E-07 |
| Normal-vs-Age(81-100Yrs) |
1.86759999998287E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.615400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.310400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.838100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.275610E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.260500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.269800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.28319999964855E-07 |
| Normal-VS-Type2 PRCC |
1.243280E-03 |
| Normal-VS-KIRP CIMP |
2.429800E-01 |
| Normal-VS-Unclassified PRCC |
2.775200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.852400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.844000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.401900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.432200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.896380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.302000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.85150000001178E-06 |
| Normal-vs-N1 |
9.078800E-01 |
| Normal-vs-N2 |
1.783900E-02 |
| N0-vs-N1 |
8.917100E-03 |
| N0-vs-N2 |
9.905000E-01 |
| N1-vs-N2 |
2.413200E-01 |
|
|
